Fundraising Fox

Zach Collins

InvestorFounder

Principal at Mission Biocapital · Co-founder, Chairman at Cavalry Biosciences · Board director at Alessa Therapeutics

San Francisco Bay Area

Writes $500K checks · typically $5M

FoundedCavalry Biosciences

About

Zach Collins, PhD-trained molecular biologist whose work contributed to Science's 2018 Breakthrough of the Year, combines scientific credibility with hands-on company-building as interim Chief Business Officer and Entrepreneur Success Partner.

Contact· self-published, not guessed

Invests in

AgTechBiotechFoodTechHealthtechMedical DevicesNew Materials

Co-founder, Chairman at Cavalry Biosciences

Intro paths

→

In turn, Zach can intro founders to Cavalry Biosciences's investors below.

Cavalry Biosciences's investors · 3

Eshelman Ventures, LLCWilmingtonMission BiocapitalSan Francisco · $500K checksVenrockPalo Alto · $500K – $10M checks

Co-founders at Cavalry Biosciences

JV
Jan van Deursen, PhDCo-founder, Advisor

Board director at Alessa Therapeutics

Intro paths

→

In turn, Zach can intro founders to Alessa Therapeutics's investors below.

Alessa Therapeutics's investors · 4

Cure VenturesBoston · since 2025Mission Bay CapitalSan FranciscoMission BiocapitalSan Francisco · $500K checks · since 2025National Institutes of Health (NIH)since 2021

Co-founders at Alessa Therapeutics

PMPamela Munster
Pamela MunsterFounder, Chief Scientific Advisor and Director

Experience

  1. Mission BioCapitalPartnercurrent2024 — presentSan Francisco Bay Area
  2. Mission BioCapitalPrincipal2021 — 2024San Francisco Bay Area
  3. Mission BioCapitalAssociate2019 — 2021San Francisco Bay Area
  4. Mission BioCapitalAnalyst2018 — 2019
  5. Alessa Therapeutics, Inc.Chief Business Officercurrent2022 — present
  6. SiteOne Therapeutics, Inc.Board Membercurrent2024 — presentSan Francisco Bay Area
  7. Jupiter BioventuresBoard Observercurrent2024 — present
  8. Jupiter BioventuresBoard Member2021 — 2024San Francisco Bay Area
  9. Cavalry BiosciencesBoard Membercurrent2024 — present
  10. Nuvig Therapeutics Inc.Board Observercurrent2021 — present
  11. MBC BiolabsEntrepreneur Success Partnercurrent2020 — presentSan Francisco Bay Area
  12. Stealth BioTech StartupBoard Obsever2021 — 2024San Francisco Bay Area
  13. Harvard Medical SchoolPostdoctoral Research Fellow2018Boston
  14. Harvard Medical SchoolGraduate Student Researcher2013 — 2018Boston
  15. Harvard Biotech IncubatorTeam Member2017 — 2018Boston
  16. Cold Spring Harbor LaboratoryUndergraduate Research Program Student2012
  17. The George Washington University Columbian College of Arts & SciencesUndergraduate Researcher2010 — 2012
  18. Cold Spring Harbor LaboratoryUndergraduate Research Program Student2011

Skills & more

Microsoft Office3PowerPoint3Matlab2Microsoft ExcelMicrosoft WordPublic Speaking2Research4Social Media2Marketing StrategyConfocal MicroscopyMolecular BiologyData Analysis
+7 moreScienceLife SciencesProgrammingCell BiologyGeneticsProject ManagementTeaching

From Zach's professional profile.

Colleagues at Mission Biocapital

Cassidy Blundell
Partner at Mission Biocapital
Chaya Patel
Principal at Mission Biocapital
Chris Carlin
Chief Operations Officer and Chief Compliance Officer at Mission Biocapital
Clay Rowland
Investment Associate at Mission Biocapital
Douglas Crawford
Managing General Partner at Mission Biocapital
Jennifer Griffin
Partner at Mission Biocapital
Johannes Fruehauf
General Partner at Mission Biocapital
Josephine Brysting
Investment Analyst at Mission Biocapital

Frequently asked questions

Who is Zach Collins?
Zach Collins, PhD-trained molecular biologist whose work contributed to Science's 2018 Breakthrough of the Year, combines scientific credibility with hands-on company-building as interim Chief Business Officer and Entrepreneur Success Partner.
Where does Zach Collins work?
Zach Collins is Co-founder, Chairman of Cavalry Biosciences and Principal at Mission Biocapital and Board director at Alessa Therapeutics.
What does Zach Collins invest in?
Zach Collins invests in AgTech, Biotech, FoodTech, Healthtech, Medical Devices, New Materials.
What check size does Zach Collins write?
Zach Collins typically writes checks of $500K.
What companies did Zach Collins found?
Zach Collins founded Cavalry Biosciences.
Where did Zach Collins go to school?
Zach Collins studied at Harvard University (Doctor of Philosophy (Ph.D.), Biological and Biomedical Sciences); The George Washington University (Bachelor of Science - BS, Biology).

Founder mafias

The George Washington University mafia28

Also came through, then founded or led a company.

Kevin MandiaMaster of Science (M.S.)Founded Mandiant +1Tom CorteseBAFounded Peloton Interactive +1Kam GhaffarianMaster's degreeFounded Quantum Space +1Jeffrey ChangBSFounded Doblet +1Rodger BermanMaster of Business Administration - MBAFounded The Zoe Report +1Ven RajuBScFounded Innovation Works

+ 21 more

Same school

Also attended Harvard University1,556

Alfred LinPartner at Sequoia CapitalChris DixonFounder & Managing Partner of a16z crypto at Andreessen HorowitzSarah TavelVenture Partner at BenchmarkDanny RimerPartner at Index VenturesLaela SturdyManaging Partner at CapitalGBill GatesCo-founder of Microsoft; Chair of the Gates Foundation

+ 1,550 more

Also attended The George Washington University186

RustyAdvisor at Clear VenturesDonna HoyleVice President & Controller at RevolutionMathew KayeAccounting Manager at RevolutionMeghan FahyDirector of Marketing at GreycroftMaurice RussoInvestor at Lerer HippeauMadeline SpatesHead of Special Projects at AlleyCorp

+ 180 more

Shared employers

Also worked at Mission BioCapital9

Robert BlazejPartner at Mission BiocapitalCassidy BlundellPartner at Mission BiocapitalDouglas CrawfordManaging General Partner at Mission BiocapitalJohannes FruehaufGeneral Partner at Mission BiocapitalPeter ParkerManaging General Partner at Mission BiocapitalChaya PatelPrincipal at Mission Biocapital

+ 3 more

Also worked at Alessa Therapeutics, Inc.1

Annie MitsakPartner at Cure Ventures

Also worked at Harvard Medical School169

Logan HilleLife Sciences Analyst at CincyTechAnkit GuptaGeneral Partner at Y CombinatorDavid MollerInvestor at Third Rock VenturesJulie YangInvestor at Third Rock VenturesTracy WilliamsInvestor at Third Rock VenturesSamuel ArbesmanVenture Partner at Lux Capital

+ 163 more

Also worked at Cold Spring Harbor Laboratory13

Ukjin (Jay) KwonPrincipal at SazzeSophia MichaelsAssociate at CVS Health VenturesTeri WilleyP2C Managing Director & Officer at Pathway to CuresAvidan RudanskyInvestor at Maccabee VenturesThomas D. LehrmanManaging Partner at Teamworthy VenturesMichael GutbrodSenior Associate at Sante Ventures

+ 7 more